Helix BioPharma (TSE:HBP) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Helix BioPharma Corp. has appointed James B. Murphy as its new Chief Financial Officer, bringing his extensive experience in finance and operations management to the company. Murphy, a seasoned consultant in the life sciences industry, is expected to drive strategic growth and support Helix’s focus on advancing its CEACAM6 platform in oncology.
For further insights into TSE:HBP stock, check out TipRanks’ Stock Analysis page.